drugset / Trial / NCT00725374
A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469)
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary purpose of this study is to compare changes in the expression of the proliferation marker Ki-67 in malignant breast tissue after treatment with tibolone or placebo in postmenopausal women who need to undergo surgery for primary breast cancer
Timeline
- Start
- 2002-12-15
- Primary completion
- 2005-04-15
- Completion
- 2005-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tibolone | Other / unclassified | 2.5 mg | — |